Full Name
Qing Yun Chong
(not current staff)


Results 1-13 of 13 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
12019A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinomaZhang, M.; Wang, B.; Chong, Q.-Y. ; Pandey, V.; Guo, Z.; Chen, R.-M.; Wang, L. ; Wang, Y.; Ma, L.; Kumar, A.P. ; Zhu, T.; Wu, Z.-S.; Yin, Z.; Basappa; Goh, B.-C. ; Lobie, P.E. 
26-Aug-2021ARTEMIN Promotes Oncogenicity and Resistance to 5-Fluorouracil in Colorectal Carcinoma by p44/42 MAPK Dependent Expression of CDH2Zhuang, Qiu-Shi; Sun, Xin-Bao; Chong, Qing-Yun ; Banerjee, Arindam ; Zhang, Min; Wu, Zheng-Sheng; Zhu, Tao; Pandey, Vijay; Lobie, Peter E. 
32017Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinomaWang J.-J. ; Chong Q.-Y. ; Sun X.-B.; You M.-L. ; Pandey V. ; Chen Y.-J. ; Zhuang Q.-S. ; Liu D.-X.; Ma L.; Wu Z.-S.; Zhu T.; Lobie P.E. 
42017Autocrine human growth hormone promotes invasive and cancer stem cell-like behavior of hepatocellular carcinoma cells by STAT3 dependent inhibition of CLAUDIN-1 expressionChen Y.-J.; You M.-L. ; Chong Q.-Y. ; Pandey V. ; Zhuang Q.-S. ; Liu D.-X.; Ma L.; Zhu T.; Lobie P.E. 
57-Apr-2021Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell LymphomaYu, Fenggang ; Syn, Nicholas L; Lu, Yanan; Chong, Qing Yun ; Lai, Junyun ; Tan, Wei Jian ; Goh, Boon Cher ; MacAry, Paul A ; Wang, Lingzhi ; Loh, Kwok Seng 
613-Aug-2019Different treatment efficacies and side effects of cytotoxicchemotherapyWang Lingzhi ; Chong Qing Yun ; Goh Boon Cher ; Soo Ross ; Li Low-Jia
72017Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cellsPandey, V ; Zhang, M; Chong, Q.-Y ; You, M ; Raquib, A.R ; Pandey, A.K ; Liu, D.-X; Liu, L; Ma, L; Jha, S ; Wu, Z.-S; Zhu, T; Lobie, P.E 
82019Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinomaPoh, H.M.; Chiou, Y.S.; Chong, Q.Y. ; Chen, R.-M. ; Rangappa, K.S.; Ma, L.; Zhu, T.; Kumar, A.P. ; Pandey, V.; Basappa, Department of Studies in Organic Chemistry, University of Mysore, Mysore, 570005, India.; Lee, S.-C. ; Lobie, P.E. 
92019Long noncoding RNA Linc00460 promotes breast cancer progression by regulating the miR-489-5p/FGF7/AKT axisZhu, Y.; Yang, L.; Chong, Q.-Y. ; Yan, H.; Zhang, W.; Qian, W.; Tan, S.; Wu, Z.; Lobie, P.E.; Zhu, T.
1011-Dec-2020Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like BehaviorWang, Yanxin; Chiou, Yi-Shiou; Chong, Qing-Yun ; Zhang, Mengyi; Rangappa, Kanchuragoppal S; Ma, Lan; Zhu, Tao; Kumar, Alan Prem ; Huang, Ruby Yun-Ju ; Pandey, Vijay; Basappa; Lobie, Peter E
112019Pharmacological inhibition of TFF3 enhances sensitivity of CMS4 colorectal carcinoma to 5-fluorouracil through inhibition of p44/42 MAPKChen, R.-M. ; Chiou, Y.-S.; Chong, Q.-Y. ; Poh, H.-M.; Tan, T.-Z. ; Zhang, M.-Y.; Ma, L.; Zhu, T.; Pandey, V.; Salundi, B.; Prem Kumar, A. ; Lobie, P.E. 
122017Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinomaChong, Q.-Y ; You, M.-L ; Pandey, V ; Banerjee, A ; Chen, Y.-J; Poh, H.-M; Zhang, M; Ma, L; Zhu, T; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India; Liu, L; Lobie, P.E 
132017Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependentYou, M.-L ; Chen, Y.-J ; Chong, Q.-Y ; Wu, M.-M; Pandey, V ; Chen, R.-M ; Liu, L; Ma, L; Wu, Z.-S; Zhu, T; Lobie, P.E